GNBT is not a vaccine company. Antigen Express, E
Post# of 36537
However, Generex has many other irons in the fire. We are waiting patient for funding through the S-1; then we will wait to see how that money is spent; then we look forward to uplisting to the NAZ; then we look for progress in creation of the MSO; hopefully, funds remain to resurrect the diabetes franchise.
Success in producing an effective COVID vaccine would enhance the company greatly. Lack of immediate success will not close Generex down.